1.	Phase III Randomized Study of TMX vs CGS-16949A in Postmenopausal Patients with Metastatic Breast Cancer Amenable to Hormone Therapy Phase: Phase III Type: Treatment Status: Closed Age: postmenopausal Sponsor: Protocol IDs: SWS-SAKK-20/88, EU-92010
2.	Phase III Randomized, Double-Blind Comparison of CGS 16949A vs Megestrol Acetate in Postmenopausal Women Who Develop Recurrent Breast Cancer While on Hormone Therapy Phase: Phase III Type: Treatment Status: Closed Age: postmenopausal/over 18 Sponsor: Protocol IDs: CG-CGS-16949A-03, NCI-V90-0170
3.	Phase III Randomized, Double-Blind Comparison of CGS 16949A vs Megestrol Acetate in Postmenopausal Women with Recurrent Breast Cancer Following One Prior Hormone Regimen Phase: Phase III Type: Treatment Status: Closed Age: postmenopausal/over 18 Sponsor: Protocol IDs: CG-CGS-16949A-06, NCI-V90-0171